CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 60 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q4 2023. The put-call ratio across all filers is 0.19 and the average weighting 1.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,568,511 | +63351.1% | 173,700 | -20.6% | 0.00% | -25.0% |
Q1 2024 | $2,472 | +67.4% | 218,800 | +17.9% | 0.00% | +100.0% |
Q4 2023 | $1,477 | +329.4% | 185,600 | +249.5% | 0.00% | +100.0% |
Q3 2023 | $344 | +62.3% | 53,100 | +54.8% | 0.00% | – |
Q2 2023 | $212 | +253.3% | 34,300 | +118.5% | 0.00% | – |
Q1 2023 | $60 | – | 15,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $180,267,308 | 53.77% |
Vida Ventures Advisors, LLC | 3,931,818 | $35,504,317 | 38.83% |
First Light Asset Management, LLC | 4,780,560 | $43,168,457 | 3.78% |
Octagon Capital Advisors LP | 2,345,075 | $21,176,027 | 3.33% |
GENERAL ATLANTIC, L.P. | 9,681,818 | $87,426,817 | 2.75% |
TCG Crossover Management, LLC | 2,890,816 | $26,104,068 | 2.72% |
5AM Venture Management, LLC | 1,245,000 | $11,242,350 | 2.52% |
Exome Asset Management LLC | 274,900 | $2,482,348 | 2.16% |
EcoR1 Capital, LLC | 5,714,404 | $51,601,068 | 1.58% |
Affinity Asset Advisors, LLC | 1,135,702 | $10,255,389 | 1.18% |